ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2025
[Benign metastasizing leiomyomatosis in postmenopause: the importance of rare case reports in clinical practice]
Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign metastasizing leiomyomatosis (BML) is an uncommon condition characterized by the presence of smooth muscle nodules outside the uterus, most often in the lungs, in patients with a history of uterine fibroids. Although typically associated with women of reproductive age, its occurrence in postmenopause has been documented, even decades after gynecologic surgery. This academic commentary examines a recently reported case in a postmenopausal patient, contextualized within the framework of available scientific evidence. Key clinical, radiologic, and histopathological aspects are discussed, emphasizing the variability of CT findings and the relevance of correlating gynecologic history with immunohistochemical analysis. Therapeutic approaches such as surgical resection, hormonal suppression, and active surveillance are reviewed in light of individual clinical progression. The importance of long-term monitoring is highlighted due to the risk of recurrence. This contribution underscores the relevance of rare cases as valuable sources of clinical insight, aiming to support diagnostic reasoning and enhance informed decision-making in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.